MiR-18b-3p通过直接抑制骨髓瘤中PTEN表达来促进细胞增殖和转移
Xiaofei Shen1,2, Guoyou Zou1,2, Zhengchun Cao1,2
1Department of Orthopedics, Yancheng First Hospital Affiliated to Nanjing University Medicine School, No. 66, Renmin South Road, Yandu District, Jiangsu Province, 224000, Yancheng City, China.
Journal of orthopaedic surgery and research
|October 22, 2025
概括
微RNA-18b-3p (miR-18b-3p) 在骨髓瘤 (OS) 中过度表达,通过向PTEN来促进瘤生长和入侵. 恢复PTEN可以逆转这些影响,这表明miR-18b-3p是OS的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 骨髓瘤 (OS) 是患有预后不佳的青少年常见的骨癌.
- 了解驱动OS病变的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 为了研究miR-18b-3p在骨髓瘤中的作用.
- 阐明miR-18b-3p在OS中的功能背后的分子机制.
主要方法:
- 使用GEO数据库和GEO2R进行miRNA表达分析.
- 通过RT-qPCR和西部涂抹验证了miR-18b-3p和PTEN表达.
- 进行了双露西法酶记者测试,功能测试 (CCK-8,伤口愈合,入侵) 和异种移植小鼠模型.
主要成果:
- miR-18b-3p的过度表达与OS患者的生存率降低有关.
- miR-18b-3p在OS组织和细胞系上升调节,促进增殖,迁移和入侵.
- PTEN是miR-18b-3p的直接目标,其恢复可以逆转致癌表型.
结论:
- miR-18b-3p通过向PTEN.p作为骨髓瘤中的瘤调节剂.
- miR-18b-3p代表了骨髓瘤治疗的潜在治疗标.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K


